Cargando…

Recomendaciones de consenso SEDAR-SEMICYUC sobre el manejo de las alteraciones de la hemostasia en los pacientes graves con infección por COVID-19

The infection by the coronavirus SARS-CoV-2, which causes the disease called COVID-19, mainly causes alterations in the respiratory system. In severely ill patients, the disease often evolves into an acute respiratory distress syndrome that can predispose patients to a state of hypercoagulability, w...

Descripción completa

Detalles Bibliográficos
Autores principales: Llau, J.V., Ferrandis, R., Sierra, P., Hidalgo, F., Cassinello, C., Gómez-Luque, A., Quintana, M., Amezaga, R., Gero, M., Serrano, A., Marcos, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier España, S.L.U. on behalf of Sociedad Española de Anestesiología, Reanimación y Terapéutica del Dolor. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245242/
https://www.ncbi.nlm.nih.gov/pubmed/32591185
http://dx.doi.org/10.1016/j.redar.2020.05.007
_version_ 1783537715998883840
author Llau, J.V.
Ferrandis, R.
Sierra, P.
Hidalgo, F.
Cassinello, C.
Gómez-Luque, A.
Quintana, M.
Amezaga, R.
Gero, M.
Serrano, A.
Marcos, P.
author_facet Llau, J.V.
Ferrandis, R.
Sierra, P.
Hidalgo, F.
Cassinello, C.
Gómez-Luque, A.
Quintana, M.
Amezaga, R.
Gero, M.
Serrano, A.
Marcos, P.
author_sort Llau, J.V.
collection PubMed
description The infection by the coronavirus SARS-CoV-2, which causes the disease called COVID-19, mainly causes alterations in the respiratory system. In severely ill patients, the disease often evolves into an acute respiratory distress syndrome that can predispose patients to a state of hypercoagulability, with thrombosis at both venous and arterial levels. This predisposition presents a multifactorial physiopathology, related to hypoxia as well as to the severe inflammatory process linked to this pathology, including the additional thrombotic factors present in many of the patients. In view of the need to optimise the management of hypercoagulability, the working groups of the Scientific Societies of Anaesthesiology-Resuscitation and Pain Therapy (SEDAR) and of Intensive, Critical Care Medicine and Coronary Units (SEMICYUC) have developed a consensus to establish guidelines for actions to be taken against alterations in haemostasis observed in severely ill patients with COVID-19. These recommendations include prophylaxis of venous thromboembolic disease in these patients, and in the peripartum, management of patients on long-term antiplatelet or anticoagulant treatment, bleeding complications in the course of the disease, and the interpretation of general alterations in haemostasis.
format Online
Article
Text
id pubmed-7245242
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Published by Elsevier España, S.L.U. on behalf of Sociedad Española de Anestesiología, Reanimación y Terapéutica del Dolor.
record_format MEDLINE/PubMed
spelling pubmed-72452422020-05-26 Recomendaciones de consenso SEDAR-SEMICYUC sobre el manejo de las alteraciones de la hemostasia en los pacientes graves con infección por COVID-19 Llau, J.V. Ferrandis, R. Sierra, P. Hidalgo, F. Cassinello, C. Gómez-Luque, A. Quintana, M. Amezaga, R. Gero, M. Serrano, A. Marcos, P. Rev Esp Anestesiol Reanim Article The infection by the coronavirus SARS-CoV-2, which causes the disease called COVID-19, mainly causes alterations in the respiratory system. In severely ill patients, the disease often evolves into an acute respiratory distress syndrome that can predispose patients to a state of hypercoagulability, with thrombosis at both venous and arterial levels. This predisposition presents a multifactorial physiopathology, related to hypoxia as well as to the severe inflammatory process linked to this pathology, including the additional thrombotic factors present in many of the patients. In view of the need to optimise the management of hypercoagulability, the working groups of the Scientific Societies of Anaesthesiology-Resuscitation and Pain Therapy (SEDAR) and of Intensive, Critical Care Medicine and Coronary Units (SEMICYUC) have developed a consensus to establish guidelines for actions to be taken against alterations in haemostasis observed in severely ill patients with COVID-19. These recommendations include prophylaxis of venous thromboembolic disease in these patients, and in the peripartum, management of patients on long-term antiplatelet or anticoagulant treatment, bleeding complications in the course of the disease, and the interpretation of general alterations in haemostasis. Published by Elsevier España, S.L.U. on behalf of Sociedad Española de Anestesiología, Reanimación y Terapéutica del Dolor. 2020 2020-05-23 /pmc/articles/PMC7245242/ /pubmed/32591185 http://dx.doi.org/10.1016/j.redar.2020.05.007 Text en © 2020 Published by Elsevier España, S.L.U. on behalf of Sociedad Española de Anestesiología, Reanimación y Terapéutica del Dolor. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Llau, J.V.
Ferrandis, R.
Sierra, P.
Hidalgo, F.
Cassinello, C.
Gómez-Luque, A.
Quintana, M.
Amezaga, R.
Gero, M.
Serrano, A.
Marcos, P.
Recomendaciones de consenso SEDAR-SEMICYUC sobre el manejo de las alteraciones de la hemostasia en los pacientes graves con infección por COVID-19
title Recomendaciones de consenso SEDAR-SEMICYUC sobre el manejo de las alteraciones de la hemostasia en los pacientes graves con infección por COVID-19
title_full Recomendaciones de consenso SEDAR-SEMICYUC sobre el manejo de las alteraciones de la hemostasia en los pacientes graves con infección por COVID-19
title_fullStr Recomendaciones de consenso SEDAR-SEMICYUC sobre el manejo de las alteraciones de la hemostasia en los pacientes graves con infección por COVID-19
title_full_unstemmed Recomendaciones de consenso SEDAR-SEMICYUC sobre el manejo de las alteraciones de la hemostasia en los pacientes graves con infección por COVID-19
title_short Recomendaciones de consenso SEDAR-SEMICYUC sobre el manejo de las alteraciones de la hemostasia en los pacientes graves con infección por COVID-19
title_sort recomendaciones de consenso sedar-semicyuc sobre el manejo de las alteraciones de la hemostasia en los pacientes graves con infección por covid-19
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245242/
https://www.ncbi.nlm.nih.gov/pubmed/32591185
http://dx.doi.org/10.1016/j.redar.2020.05.007
work_keys_str_mv AT llaujv recomendacionesdeconsensosedarsemicyucsobreelmanejodelasalteracionesdelahemostasiaenlospacientesgravesconinfeccionporcovid19
AT ferrandisr recomendacionesdeconsensosedarsemicyucsobreelmanejodelasalteracionesdelahemostasiaenlospacientesgravesconinfeccionporcovid19
AT sierrap recomendacionesdeconsensosedarsemicyucsobreelmanejodelasalteracionesdelahemostasiaenlospacientesgravesconinfeccionporcovid19
AT hidalgof recomendacionesdeconsensosedarsemicyucsobreelmanejodelasalteracionesdelahemostasiaenlospacientesgravesconinfeccionporcovid19
AT cassinelloc recomendacionesdeconsensosedarsemicyucsobreelmanejodelasalteracionesdelahemostasiaenlospacientesgravesconinfeccionporcovid19
AT gomezluquea recomendacionesdeconsensosedarsemicyucsobreelmanejodelasalteracionesdelahemostasiaenlospacientesgravesconinfeccionporcovid19
AT quintanam recomendacionesdeconsensosedarsemicyucsobreelmanejodelasalteracionesdelahemostasiaenlospacientesgravesconinfeccionporcovid19
AT amezagar recomendacionesdeconsensosedarsemicyucsobreelmanejodelasalteracionesdelahemostasiaenlospacientesgravesconinfeccionporcovid19
AT gerom recomendacionesdeconsensosedarsemicyucsobreelmanejodelasalteracionesdelahemostasiaenlospacientesgravesconinfeccionporcovid19
AT serranoa recomendacionesdeconsensosedarsemicyucsobreelmanejodelasalteracionesdelahemostasiaenlospacientesgravesconinfeccionporcovid19
AT marcosp recomendacionesdeconsensosedarsemicyucsobreelmanejodelasalteracionesdelahemostasiaenlospacientesgravesconinfeccionporcovid19